Genetic Neuropsychiatric panel 

is a test analyzing segments of DNA (genes) linked to certain structural and biochemical features of the brain.  The genes composed of nucleotides, a sequence of amino acids.  This sequence may slightly differ between individuals, which can affect a gene’s function, eventually predisposing or causing a mental disease.  These variations in the nucleotides’ sequences, known as Single-Nucleotide Polymorphism (SNP) is a subject of intense study in all fields of medicine, including Psychiatry, since the technology became possible.  An effected gene might affect the brain functions on a different manner: it may cause reduction of neurotransmitters, may cause the brain receptors be less sensitive to the transmitters, may cause problems with storage and release of neurotransmitters in the brain, and so on.  The Neuropsychiatric panel is also including the genes responsible for psychiatric medications metabolism.  The panel shows, which of the medications might be inappropriate to take for a particular individual.  The test is the most informative when accompanied by another test - Urine Neurotransmitters test, which is a biochemical test, reflecting on the genetic effect on the brain neurotransmitters levels.